Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ENGN
#2490
enGene Holdings Inc. Common Stock
10.110
0
+0.20%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.20%
Monthly Change
-9.25%
6 month change
+20.36%
Year Change
+20.36%
Previous Close
10.090
0
Open
10.110
0
Bid
Ask
Low
10.110
0
High
10.110
0
Volume
9
Markets
US Stock Market
Healthcare
ENGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
2025
TTM
Dividends per share
0
0
0
0
Dividend yield %
0
0
0
0
Payout ratio %
0
0
0
0
News
Top SMID Cap Biotech Stocks to Watch According to Morgan Stanley
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Jefferies initiates coverage on Engene stock with Buy rating
enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 (NASDAQ:ENGN)
Citizens reiterates Market Outperform rating on Engene stock with $21 target
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)
enGene completes enrollment in bladder cancer treatment trial
H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program
enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program
FDA selects enGene’s bladder cancer therapy for development program